Rapid urinary trypsinogen-2 test in the early diagnosis of acute pancreatitis: a meta-analysis.

Clin Biochem

Department of Clinical Laboratory Medicine, Institute of Surgery Research, Daping Hospital, The Third Military Medical University, Chongqing 400042, China.

Published: September 2012

Objectives: Urinary trypsinogen-2 has been implicated as a promising biomarker for the early diagnosis of acute pancreatitis (AP). The meta-analysis was used to establish the overall accuracy of urinary trypsinogen-2 test for diagnosing AP.

Methods: Based on comprehensive searches of the PubMed and Embase databases, we identified and abstracted outcome data from all articles evaluating the diagnostic value of urinary trypsinogen-2. A summary estimate for sensitivity, specificity, 95% confidence region and 95% prediction region was calculated using the bivariate random-effects approach.

Results: The meta-analysis included 13 studies (2342 patients, the proportion of severe AP from 13.21% to 30.00%). Overall, the pooled sensitivity was 82.3% (95%CI 79.3%-85.1%) and specificity was 93.5% (95%CI 92.2%-94.6%). The diagnostic odds ratios (DOR) was 85.23 (95%CI 40.14-180.99). The area under the summary ROC curve (AUC) was 0.9673.

Conclusion: The urinary trypsinogen-2 test is a reliable and rapid method for the early diagnosis of AP.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2012.04.028DOI Listing

Publication Analysis

Top Keywords

urinary trypsinogen-2
20
trypsinogen-2 test
12
early diagnosis
12
diagnosis acute
8
acute pancreatitis
8
pancreatitis meta-analysis
8
trypsinogen-2
5
rapid urinary
4
test early
4
meta-analysis objectives
4

Similar Publications

Objective: Few reports have explored the application of urinary trypsinogen-2 measurement in the early diagnosis of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis, and none have demonstrated the benefits of noninvasive testing. This study aimed to evaluate the clinical application of the rapid urinary trypsinogen-2 dipstick test (Nipro, Japan) compared with serum amylase and lipase levels for the early diagnosis of post-ERCP pancreatitis (PEP).

Methods: A total of 100 consecutive patients (54 men and 46 women) who were admitted and underwent ERCP at Tokyo Medical University Hospital from August 2021 to December 2021 were recruited.

View Article and Find Full Text PDF

Aim: Early diagnosis of acute pancreatitis is crucial, and urinary trypsinogen has been recently reported as a useful biomarker for diagnosing acute pancreatitis. We aimed to evaluate the impact of renal dysfunction on the diagnostic performance of urinary trypsinogen-2 for acute pancreatitis.

Methods: We conducted a retrospective study using the clinical data of patients who visited the Department of Emergency and Critical Care at the University of Tokyo Hospital between 1 October, 2021, and 30 June, 2022.

View Article and Find Full Text PDF

Background And Aim: Local complications of acute pancreatitis (AP) carry risks of morbidity/mortality. This study aimed to assess whether urinary trypsinogen-2 levels and Bedside Index for Severity in Acute Pancreatitis (BISAP) score on admission predicted subsequent local complications.

Methods: One hundred and forty-four consecutive patients with AP were prospectively followed till 6 months after discharge.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted in Japan to validate the effectiveness of urinary trypsinogen-2 dipstick tests and other related markers in diagnosing acute pancreatitis.
  • The research involved 94 patients and assessed the sensitivity and specificity of these markers alongside CT imaging criteria.
  • The results confirmed that the urinary trypsinogen-2 dipstick test is a reliable diagnostic tool, and both urinary trypsinogen-2 and TAP levels can indicate the presence of inflammation outside the pancreas.
View Article and Find Full Text PDF

The present study investigated the effects of dual specificity phosphatase 1 (DUSP1) gene silencing using lentiviral vector-mediated small interfering (si)RNA on the release of proinflammatory cytokines through the regulation of the mitogen‑activated protein kinase (MAPK) signaling pathway in mice with acute pancreatitis (AP). Two siRNA‑DUSP1 sequences and one scramble siRNA sequence were designed, and the expression of DUSP1 was detected using western blot analysis to screen for the one with a higher interference rate. An AP mouse model was established, and KM mice were assigned to either a control, siRNA, AP, AP+PD98059, AP+scramble, AP+siRNA or AP+PD98059+siRNA group.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!